Catalyst Wire Dossier Catalyst Wire Dossier

XELPROS

LATANOPROST · Sun Pharmaceutical Industries, Inc.
Drug timelines are a Plus or Pro feature.

3 regulatory and trial events tracked for XELPROS, covering 2018-09-12 to 2024-10-09. Get the full timeline:

Most recent: FDA Approved: XELPROS — Supplemental Application (Sun Pharmaceutical Industries, Inc.)

See pricing